Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
iShares MSCI Europe Small-Cap ETF
IEUS
$169M
| $2.42M | ﹤0.01% |
36,019
+31,163
| +642% | +$1.94M |
2024 Q4
2 quarters
|
|
2927
FT Vest US Equity Deep Buffer ETF June
DJUN
$358M
| $2.42M | ﹤0.01% |
53,652
+7,589
| +16% | +$325K |
2024 Q4
2 quarters
|
|
2928
Northern Trust iBoxx 3-Year Target Duration TIPS ETF
TDTT
$2.5B
| $2.41M | ﹤0.01% |
99,551
-7,172
| -7% | -$173K |
2024 Q4
2 quarters
|
|
2929
Axalta
AXTA
$6.82B
| $2.41M | ﹤0.01% |
81,130
+7,088
| +10% | +$221K |
2024 Q4
2 quarters
|
|
2930
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$490M
| $2.4M | ﹤0.01% |
45,171
+6,769
| +18% | +$346K |
2024 Q4
2 quarters
|
|
2931
Adeia
ADEA
$2.79B
| $2.4M | ﹤0.01% |
169,871
-5,746
| -3% | -$74.3K |
2024 Q4
2 quarters
|
|
2932
First Trust Japan AlphaDEX Fund
FJP
$268M
| $2.4M | ﹤0.01% |
40,196
+726
| +2% | +$40.9K |
2024 Q4
2 quarters
|
|
2933
Innovator Growth-100 Power Buffer ETF April
NAPR
$213M
| $2.39M | ﹤0.01% |
46,912
+3,516
| +8% | +$171K |
2024 Q4
2 quarters
|
|
2934
Telus
TU
$12.9B
| $2.39M | ﹤0.01% |
149,001
-26,816
| -15% | -$416K |
2024 Q4
2 quarters
|
|
2935
Northrim BanCorp
NRIM
$546M
| $2.39M | ﹤0.01% |
102,512
+7,388
| +8% | +$154K |
2024 Q4
2 quarters
|
|
2936
iShares Global Clean Energy ETF
ICLN
$2.19B
| $2.39M | ﹤0.01% |
182,288
-697,422
| -79% | -$8.55M |
2024 Q4
2 quarters
|
|
2937
Innovator US Equity Ultra Buffer ETF January
UJAN
$254M
| $2.39M | ﹤0.01% |
58,989
+21,458
| +57% | +$831K |
2024 Q4
2 quarters
|
|
2938
Equinor
EQNR
$99.9B
| $2.38M | ﹤0.01% |
94,768
+28,634
| +43% | +$692K |
2024 Q4
2 quarters
|
|
|
BFK
2939
DELISTED
BlackRock Municipal Income Trust
BFK
| $2.38M | ﹤0.01% |
247,948
-11,197
| -4% | -$107K |
2024 Q4
2 quarters
|
|
2940
iShares CMBS ETF
CMBS
$458M
| $2.37M | ﹤0.01% |
48,634
-8,117
| -14% | -$391K |
2024 Q4
2 quarters
|
|
|
RJMG
2941
DELISTED
FT Raymond James Multicap Growth Equity ETF
RJMG
| $2.37M | ﹤0.01% |
97,615
+11,175
| +13% | +$249K |
2024 Q4
2 quarters
|
|
2942
Stewart Information Services
STC
$1.55B
| $2.37M | ﹤0.01% |
36,355
-17,621
| -33% | -$1.13M |
2024 Q4
2 quarters
|
|
2943
Carter's
CRI
$1.16B
| $2.36M | ﹤0.01% |
78,313
+16,407
| +27% | +$556K |
2024 Q4
2 quarters
|
|
2944
Natural Gas Services Group
NGS
$422M
| $2.35M | ﹤0.01% |
91,243
+52,115
| +133% | +$1.17M |
2024 Q4
2 quarters
|
|
2945
Gold Fields
GFI
$31.9B
| $2.35M | ﹤0.01% |
99,492
+73,222
| +279% | +$1.68M |
2024 Q4
2 quarters
|
|
2946
Kiniksa Pharmaceuticals
KNSA
$5.87B
| $2.35M | ﹤0.01% |
84,915
-18,758
| -18% | -$477K |
2024 Q4
2 quarters
|
|
2947
First Financial Corp
THFF
$880M
| $2.35M | ﹤0.01% |
43,340
+34,183
| +373% | +$1.7M |
2024 Q4
2 quarters
|
|
|
IGA
2948
Voya Global Advantage and Premium Opportunity Fund
IGA
$153M
| $2.35M | ﹤0.01% |
236,434
+39,794
| +20% | +$389K |
2024 Q4
2 quarters
|
|
2949
Moderna
MRNA
$75.4B
| $2.35M | ﹤0.01% |
85,068
-18,429
| -18% | -$485K |
2024 Q4
2 quarters
|
|
|
MPT
2950
Medical Properties Trust
MPT
$2.01B
| $2.35M | ﹤0.01% |
544,334
-12,732
| -2% | -$62.9K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.